Prostaglandin E for maintaining ductal patency in neonates with ductus-dependent cardiac lesions

To determine the effectiveness of PGE1 in maintaining patency of the ductus arteriosus and decreasing mortality in ductal-dependent cardiac lesions and to determine the safety of PGE1 when used in ductal-dependent cardiac lesions both short term (less than 120 hours) and long term (120 hours or greater).

This is a protocol.

Share/Save